Language

News topic

Active ingredient Ezetimibe ,Atorvastatin

Current shortage notices for the active ingredient Ezetimibe ,Atorvastatin, structured by product, country and reporting period.

4 notices

← All shortages

What the Ezetimibe ,Atorvastatin notices indicate for the supply chain

The 4 consolidated notices from Belgium are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Belgium

Myatorlip 10 mg - 10 mg film-coat. tabl. 90

Active ingredient: Ezetimibe ,Atorvastatin

View notice details →
Belgium

Myatorlip 10 mg - 20 mg film-coat. tabl. 90

Active ingredient: Ezetimibe ,Atorvastatin

View notice details →
Belgium

Myatorlip 10 mg - 20 mg film-coat. tabl. 90

Active ingredient: Ezetimibe ,Atorvastatin

View notice details →
Belgium

Myatorlip 10 mg - 10 mg film-coat. tabl. 90

Active ingredient: Ezetimibe ,Atorvastatin

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.